Medicare Enrolled
Dr. Abdul Ahad Hayee, MD
Pain Medicine · Flower Mound, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hayee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hayee? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hayee
Dr. Abdul Ahad Hayee is a pain medicine in Flower Mound, TX, with 18 years in practice. Based on federal Medicare data, Dr. Hayee performed 4,072 Medicare services across 1,044 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hayee received a total of $9,960 from 62 pharmaceutical and/or device companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hayee is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 17% volume in TX$ $9,960 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,072
Medicare services
Top 17% in TX for pain medicine
1,044
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~226 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 1,163 | $0 | $1 |
| Office visit, established patient (30-39 min) | 693 | $86 | $254 |
| Administration of psychological or neuropsychological test, first 30 minutes | 413 | $32 | $95 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 325 | $180 | $402 |
| Drug screening test | 318 | $59 | $162 |
| Contrast dye for imaging, lower concentration | 200 | $0 | $3 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 140 | $8 | $22 |
| Injection, methylprednisolone acetate, 80 mg | 133 | $9 | $25 |
| Anti-nausea injection (ondansetron/Zofran) | 108 | $0 | $5 |
| Injection of substance into lower spine canal using imaging guidance | 57 | $178 | $758 |
| Injection, midazolam hydrochloride, per 1 mg | 56 | $0 | $1 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $36 | $99 |
| Injection of additional new drug or substance into vein | 48 | $12 | $34 |
| Injection of substance into middle or upper spine canal using imaging guidance | 46 | $180 | $758 |
| New patient office visit (45-59 min) | 41 | $114 | $379 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 35 | $207 | $848 |
| Infusion, normal saline solution , 1000 cc | 28 | $2 | $21 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 27 | $90 | $424 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 24 | $46 | $139 |
| Injection of drug or substance into vein | 24 | $27 | $78 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 22 | $466 | $1,735 |
| Injection, methylprednisolone acetate, 40 mg | 22 | $6 | $14 |
| Unclassified drugs | 22 | $1 | $52 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 21 | $256 | $750 |
| Joint injection, major joint | 19 | $57 | $163 |
| Fluoroscopic guidance for needle placement | 19 | $87 | $189 |
| Ultrasound study of arm and leg arteries | 15 | $59 | $167 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
49.0% medium
49.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,960
Total received (2018-2024)
Avg $1,423/year across 7 years
Top 26% in TX for pain medicine
62
Companies
430
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,933 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$984
2023$1,002
2022$439
2021$1,247
2020$855
2019$3,007
2018$2,426
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$1,814
Medtronic USA, Inc.
$1,141
Medtronic Vascular, Inc.
$1,099
Collegium Pharmaceutical, Inc.
$933
Abbott Laboratories
$444
Forte Bio-Pharma LLC
$426
BioDelivery Sciences International, Inc.
$309
SI-BONE, INC.
$299
ABBVIE INC.
$281
PFIZER INC.
$268
BOSTON SCIENTIFIC CORPORATION
$236
Almatica Pharma LLC
$218
Medtronic, Inc.
$218
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$161
Sentynl Therapeutics, Inc.
$156
ARBOR PHARMACEUTICALS, INC.
$153
Takeda Pharmaceuticals U.S.A., Inc.
$110
Daiichi Sankyo Inc.
$109
DePuy Synthes Sales Inc.
$102
Flexion Therapeutics, Inc.
$81
Allergan, Inc.
$74
Boston Scientific Corporation
$73
Relievant Medsystems, Inc.
$73
AstraZeneca Pharmaceuticals LP
$68
Neuronetics, Inc.
$64
Novartis Pharmaceuticals Corporation
$63
Arbor Pharmaceuticals, Inc.
$62
SI-BONE, Inc.
$56
Purdue Pharma L.P.
$50
Zyla Life Sciences, Inc.
$46
Allergan Inc.
$44
Biohaven Pharmaceutical Holding Company Ltd.
$43
INSYS Therapeutics Inc
$40
PAINTEQ LLC
$39
Masimo Corporation
$38
BIOTRONIK NRO, Inc.
$38
Virtus Pharmaceuticals LLC
$37
Shionogi Inc
$36
Horizon Therapeutics plc
$36
Vertical Pharmaceuticals, LLC
$36
RedHill Biopharma Inc.
$30
Kowa Pharmaceuticals America, Inc.
$25
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$24
Fidia Pharma USA Inc.
$24
Bioventus LLC
$21
Curonix LLC
$20
Assertio Therapeutics, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$19
Indivior Inc.
$18
FORTE BIO-PHARMA LLC
$18
Epimed International, Inc
$16
Spinal Simplicity, LLC
$16
Stimwave Technologies Incorporated
$15
Pylant Medical
$14
Averitas Pharma Inc.
$14
AbbVie Inc.
$14
Orthogenrx Inc.
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Scilex Pharmaceuticals Inc.
$13
Azurity Pharmaceuticals, Inc.
$13
Zyla Life Sciences
$13
Lilly USA, LLC
$13
Top 3 companies account for 40.7% of total payments
Associated products mentioned in payments ›
AIMOVIG · Amitiza · BELBUCA · BIOTRONIK · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cambia · Catheters and Needles · ClosureFast · DUEXIS · Durolane · EMGALITY · ETERNA · Epidural needles and catheters · Evekeo · GRALISE · GenVisc 850 · HA MINUTEMAN G3-R · HYMOVIS · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LACTULOSE · LEVORPHANOL TARTRATE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · MONOVISC · MOVANTIK · Morphabond ER · Motegrity · Movantik · NALOCET · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nucynta · OCTRODE · OSTEOCOOL RF ABLATION · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · QULIPTA · QUTENZA · RAYOS · RELISTOR · RELISTOR ORAL · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPRIX · SUBLOCADE · SUBSYS · SYMPROIC · Seglentis · Senza · Senza II · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Symproic · UBRELVY · VECTRIS · VENASEAL · Varithena Administration Pack · VenaSeal · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $245 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
85
Per 100K population
9.0
County median income
$108,185
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL FLOWER MOUND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hayee is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hayee experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Hayee performed 1,163 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hayee receive payments from pharmaceutical companies?
Yes. Dr. Hayee received a total of $9,960 from 62 companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hayee's costs compare to other pain medicines in Flower Mound?
Dr. Hayee's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hayee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Flower Mound
Browse pain medicines in Flower Mound ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp..
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology